San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Molecular Assemblies is raising $40,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Michael Kamdar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Molecular Assemblies
Molecular Assemblies, Inc. is a private biotechnology company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high-quality, sequence-specific DNA reliably, affordably, and sustainably. Molecular Assemblies technology will unleash a new generation of DNA synthesis for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego.

To learn more about Molecular Assemblies, visit http://www.molecularassemblies.com/

Contact:
Michael Kamdar, President and Chief Executive Officer
858-257-3078
michael@molecularassemblies.com
https://www.linkedin.com/in/michael-kamdar-085a7aa/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved